Sun Pharma Advanced Research Company Limited

NSE: SPARC

Compare with…

Employs 279 permanent employees and workers, −11.7% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 31 Dec 2024 was ₹15 cr.

Headcount

Annual, from the BRSR filed with NSE (as of 31 March each year)

Permanent
Contract / other
As ofScopePermanentChange (%)Contract / otherChange (%)
31 Mar 2023Standalone407—172—
31 Mar 2024Group⚠4092(0.5%)19422(12.8%)
31 Mar 2025Group316−93(22.7%)1962(1.0%)
31 Mar 2026Group279−37(11.7%)187−9(4.6%)
  • ⚠The reporting scope changed from the previous period, so the two are not comparable.

Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.

Financials (₹ cr)

Revenue (₹ cr)
Employee cost (₹ cr)
Net profit (₹ cr)
PeriodRevenue (₹ cr)Change (%)Employee cost (₹ cr)Change (%)Net profit (₹ cr)Change (%)Flags
Quarter ended 31 Dec 2024152(15.9%)26−2(8.2%)-8028(26.0%)
Quarter ended 30 Sept 202413−4(23.5%)29−0(0.5%)-108−11(11.2%)
Quarter ended 30 Jun 2024170(1.5%)292(8.3%)-9710(9.2%)
Quarter ended 31 Mar 2024173(19.5%)27−3(10.9%)-107−7(7.1%)
Quarter ended 31 Dec 202314−7(34.6%)30−1(2.4%)-100−13(15.3%)
Quarter ended 30 Sept 202321−3(11.6%)31−0(1.3%)-869(9.4%)
Quarter ended 30 Jun 202324−24(49.8%)311(4.1%)-95−13(16.3%)
Quarter ended 31 Mar 202348−83(63.6%)304(16.5%)-82−92(907.8%)
Quarter ended 31 Dec 2022131106(419.4%)263(11.2%)1081(114.3%)
Quarter ended 31 Mar 202225−37(59.4%)23−1(4.8%)-71−55(348.6%)⚠
Quarter ended 31 Dec 20216234(123.0%)240(1.3%)-1639(71.3%)⚠
Quarter ended 30 Sept 2021286(26.7%)24−2(6.2%)-556(10.2%)⚠
Quarter ended 30 Jun 202122−6(21.6%)263(15.5%)-61−5(8.2%)⚠
Quarter ended 31 Mar 2021286(28.7%)22−1(2.4%)-5711(16.1%)⚠
Quarter ended 31 Dec 2020224(23.6%)23−0(0.8%)-6816(19.0%)⚠
Quarter ended 30 Sept 202018−168(90.5%)23−1(4.9%)-83−140(247.3%)⚠
Quarter ended 30 Jun 2020185163(716.6%)24−0(1.6%)57156(156.9%)⚠
Quarter ended 31 Mar 2020233(15.9%)242(7.1%)-100−44(79.3%)⚠
Quarter ended 31 Dec 2019202(14.0%)23−1(2.2%)-568(12.1%)⚠
Quarter ended 30 Sept 201917−0(0.8%)231(2.7%)-6331(32.9%)⚠
Quarter ended 30 Jun 201917−68(79.6%)233(17.3%)-94−85(907.4%)⚠
Quarter ended 31 Mar 20198565(326.7%)19−2(9.5%)-960(86.5%)⚠
Quarter ended 31 Dec 201820−41(67.6%)211(7.1%)-69−66(2575.2%)⚠
Quarter ended 30 Sept 20186145(265.0%)20−0(2.4%)-362(96.0%)⚠
Quarter ended 30 Jun 201817−3(16.3%)20−4(15.9%)-64−67(2700.0%)⚠
Quarter ended 31 Mar 201820—24—2—⚠